Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368784 · ClinicalTrials.gov registry record
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 426
- Enrollment target
NCT00368784 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 426 participants.
The verdict
NCT00368784 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 426 participants
- Enrollment target
Study Summary
This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our knowledge about immune mediated skin disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2007-01 |
| Est. Completion | 2020-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368784
The ClinicalTrials.gov registry entry for NCT00368784 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 426 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00368784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00368784 about?
NCT00368784 is a clinical study titled "T Cell Repertoire Analysis of Immune Mediated Skin Diseases". This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our k...
What is the current status of trial NCT00368784?
This trial is currently completed. The enrollment target is 426 participants. The study started on 2007-01. Estimated completion is 2020-11.
Who is sponsoring clinical trial NCT00368784?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.